245 related articles for article (PubMed ID: 17976390)
1. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.
Obrosova IG; Xu W; Lyzogubov VV; Ilnytska O; Mashtalir N; Vareniuk I; Pavlov IA; Zhang J; Slusher B; Drel VR
Free Radic Biol Med; 2008 Mar; 44(6):972-81. PubMed ID: 17976390
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice.
Drel VR; Pacher P; Stavniichuk R; Xu W; Zhang J; Kuchmerovska TM; Slusher B; Obrosova IG
Int J Mol Med; 2011 Oct; 28(4):629-35. PubMed ID: 21617845
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase inhibition as a novel therapeutic approach against intraepidermal nerve fiber loss and neuropathic pain associated with advanced diabetic neuropathy: a commentary on "PARP Inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy".
Pacher P
Free Radic Biol Med; 2008 Mar; 44(6):969-71. PubMed ID: 18194675
[No Abstract] [Full Text] [Related]
4. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.
Shevalye H; Stavniichuk R; Xu W; Zhang J; Lupachyk S; Maksimchyk Y; Drel VR; Floyd EZ; Slusher B; Obrosova IG
Biochem Pharmacol; 2010 Apr; 79(7):1007-14. PubMed ID: 19945439
[TBL] [Abstract][Full Text] [Related]
5. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
Drel VR; Xu W; Zhang J; Pavlov IA; Shevalye H; Slusher B; Obrosova IG
Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
[TBL] [Abstract][Full Text] [Related]
6. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
Ilnytska O; Lyzogubov VV; Stevens MJ; Drel VR; Mashtalir N; Pacher P; Yorek MA; Obrosova IG
Diabetes; 2006 Jun; 55(6):1686-94. PubMed ID: 16731831
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.
Drel VR; Lupachyk S; Shevalye H; Vareniuk I; Xu W; Zhang J; Delamere NA; Shahidullah M; Slusher B; Obrosova IG
Endocrinology; 2010 Jun; 151(6):2547-55. PubMed ID: 20357221
[TBL] [Abstract][Full Text] [Related]
9. Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation.
Dieckmann A; Kriebel M; Andriambeloson E; Ziegler D; Elmlinger M
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):132-8. PubMed ID: 22020669
[TBL] [Abstract][Full Text] [Related]
10. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.
Vareniuk I; Pacher P; Pavlov IA; Drel VR; Obrosova IG
Int J Mol Med; 2009 May; 23(5):571-80. PubMed ID: 19360314
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
[TBL] [Abstract][Full Text] [Related]
12. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.
Lupachyk S; Shevalye H; Maksimchyk Y; Drel VR; Obrosova IG
Free Radic Biol Med; 2011 May; 50(10):1400-9. PubMed ID: 21300148
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
Vareniuk I; Pavlov IA; Obrosova IG
Diabetologia; 2008 Nov; 51(11):2126-33. PubMed ID: 18802679
[TBL] [Abstract][Full Text] [Related]
14. Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy.
Li F; Drel VR; Szabó C; Stevens MJ; Obrosova IG
Diabetes; 2005 May; 54(5):1514-22. PubMed ID: 15855340
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase inhibition reverses nitrergic neurovascular dysfunctions in penile erectile tissue from streptozotocin-diabetic mice.
Nangle MR; Cotter MA; Cameron NE
J Sex Med; 2010 Oct; 7(10):3396-403. PubMed ID: 20456626
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration.
Hulse RP; Beazley-Long N; Ved N; Bestall SM; Riaz H; Singhal P; Ballmer Hofer K; Harper SJ; Bates DO; Donaldson LF
Clin Sci (Lond); 2015 Oct; 129(8):741-56. PubMed ID: 26201024
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.
Drel VR; Pacher P; Vareniuk I; Pavlov IA; Ilnytska O; Lyzogubov VV; Bell SR; Groves JT; Obrosova IG
Int J Mol Med; 2007 Dec; 20(6):783-92. PubMed ID: 17982684
[TBL] [Abstract][Full Text] [Related]
19. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.
Obrosova IG; Li F; Abatan OI; Forsell MA; Komjáti K; Pacher P; Szabó C; Stevens MJ
Diabetes; 2004 Mar; 53(3):711-20. PubMed ID: 14988256
[TBL] [Abstract][Full Text] [Related]
20. PARP inhibitors attenuate chemotherapy-induced painful neuropathy.
Brederson JD; Joshi SK; Browman KE; Mikusa J; Zhong C; Gauvin D; Liu X; Shi Y; Penning TD; Shoemaker AR; Giranda VL
J Peripher Nerv Syst; 2012 Sep; 17(3):324-30. PubMed ID: 22971094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
